DNA damage response at telomeres boosts the transcription of SARS‐CoV‐2 receptor ACE2 during aging
暂无分享,去创建一个
J. Shay | C. Tripodo | F. d’Adda di Fagagna | F. Rossiello | S. Sepe | F. Iannelli | A. Di Napoli | V. Cancila | Busola R Alabi | Valentina Matti | Giada Cicio | Matteo Cabrini | Eugenia Marinelli | Alessia di Lillo
[1] S. Crooke,et al. Antisense technology: an overview and prospectus , 2021, Nature Reviews Drug Discovery.
[2] D. Baralle,et al. A novel ACE2 isoform is expressed in human respiratory epithelia and is upregulated in response to interferons and RNA respiratory virus infection , 2021, Nature Genetics.
[3] É. B. Rangel,et al. COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection , 2021, European Journal of Clinical Microbiology & Infectious Diseases.
[4] R. DePinho,et al. Telomeres: history, health, and hallmarks of aging , 2021, Cell.
[5] Raphael Gottardo,et al. Integrated analysis of multimodal single-cell data , 2020, Cell.
[6] A. Vaiserman,et al. Telomere Length as a Marker of Biological Age: State-of-the-Art, Open Issues, and Future Perspectives , 2021, Frontiers in Genetics.
[7] A. Chinnaiyan,et al. Targeting transcriptional regulation of SARS-CoV-2 entry factors ACE2 and TMPRSS2 , 2020, Proceedings of the National Academy of Sciences.
[8] M. O’Reilly,et al. Neonatal hyperoxia enhances age-dependent expression of SARS-CoV-2 receptors in mice , 2020, Scientific Reports.
[9] M. Blasco,et al. Telomerase treatment prevents lung profibrotic pathologies associated with physiological aging , 2020, The Journal of cell biology.
[10] Irving L. Weissman,et al. A single-cell transcriptomic atlas characterizes ageing tissues in the mouse , 2020, Nature.
[11] Quanlong Jiang,et al. Individual variation of the SARS‐CoV‐2 receptor ACE2 gene expression and regulation , 2020, Aging cell.
[12] M. Harting,et al. Understanding the age divide in COVID-19: why are children overwhelmingly spared? , 2020, American journal of physiology. Lung cellular and molecular physiology.
[13] Supinda Bunyavanich,et al. Nasal Gene Expression of Angiotensin-Converting Enzyme 2 in Children and Adults. , 2020, JAMA.
[14] Abraham Aviv,et al. Telomeres and COVID‐19 , 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[15] V. Jhanji,et al. Expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in human primary conjunctival and pterygium cell lines and in mouse cornea , 2020, Eye.
[16] Martin Stahl,et al. Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2 , 2020, Cell.
[17] Roland Eils,et al. SARS‐CoV‐2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells , 2020, The EMBO journal.
[18] C. Whittaker,et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis , 2020, The Lancet Infectious Diseases.
[19] Linqi Zhang,et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor , 2020, Nature.
[20] Fabian J Theis,et al. SARS-CoV-2 Receptor ACE2 is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Enriched in Specific Cell Subsets Across Tissues , 2020, SSRN Electronic Journal.
[21] A. Walls,et al. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein , 2020, Cell.
[22] G. Herrler,et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.
[23] Qiang Zhou,et al. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2 , 2020, Science.
[24] K. Yuen,et al. Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.
[25] Yan Zhao,et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.
[26] Kai Zhao,et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.
[27] W. Zuo,et al. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov , 2020, bioRxiv.
[28] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[29] Lin S. Chen,et al. Determinants of telomere length across human tissues , 2019, bioRxiv.
[30] Ba,et al. Nasal Gene Expression of Angiotensin-Converting Enzyme 2 in Children and Adults , 2020 .
[31] O. Dreesen,et al. Inhibition of DNA damage response at telomeres improves the detrimental phenotypes of Hutchinson–Gilford Progeria Syndrome , 2019, Nature Communications.
[32] F. d’Adda di Fagagna,et al. Functional transcription promoters at DNA double-strand breaks mediate RNA-driven phase separation of damage response factors , 2019, Nature Cell Biology.
[33] P. Opresko,et al. The impact of oxidative DNA damage and stress on telomere homeostasis , 2019, Mechanisms of Ageing and Development.
[34] L. Mullenders. Solar UV damage to cellular DNA: from mechanisms to biological effects , 2018, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[35] J. Shay,et al. Long-term culture and cloning of primary human bronchial basal cells that maintain multipotent differentiation capacity and CFTR channel function. , 2018, American journal of physiology. Lung cellular and molecular physiology.
[36] G. Danuser,et al. A method for measuring the distribution of the shortest telomeres in cells and tissues , 2017, Nature Communications.
[37] G. Shivashankar,et al. Damage-induced lncRNAs control the DNA damage response through interaction with DDRNAs at individual double-strand breaks , 2017, Nature Cell Biology.
[38] A. Rauf,et al. Renin-angiotensin-aldosterone (RAAS): The ubiquitous system for homeostasis and pathologies. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[39] Wei Wang,et al. DNA damage-induced nuclear factor-kappa B activation and its roles in cancer progression , 2017, Journal of cancer metastasis and treatment.
[40] B. Yousefi,et al. The crosstalk between Wnt/β-catenin signaling pathway with DNA damage response and oxidative stress: Implications in cancer therapy. , 2017, DNA repair.
[41] Piero Carninci,et al. DNA damage response inhibition at dysfunctional telomeres by modulation of telomeric DNA damage response RNAs , 2017, Nature Communications.
[42] Andrew D. Rouillard,et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update , 2016, Nucleic Acids Res..
[43] P. Pelicci,et al. P66SHC deletion improves fertility and progeric phenotype of late‐generation TERC‐deficient mice but not their short lifespan , 2016, Aging cell.
[44] N. Dantuma,et al. Spatiotemporal regulation of posttranslational modifications in the DNA damage response , 2016, The EMBO journal.
[45] V. Bordignon,et al. Endoplasmic Reticulum Stress, Genome Damage, and Cancer , 2015, Front. Oncol..
[46] C. Litterst,et al. Quantitative telomerase enzyme activity determination using droplet digital PCR with single cell resolution , 2014, Nucleic acids research.
[47] J. Lingner,et al. A quantitative telomeric chromatin isolation protocol identifies different telomeric states , 2013, Nature Communications.
[48] J. Diedrich,et al. A two-step mechanism for TRF2-mediated chromosome end protection , 2013, Nature.
[49] Jian Ye,et al. Primer-BLAST: A tool to design target-specific primers for polymerase chain reaction , 2012, BMC Bioinformatics.
[50] Piero Carninci,et al. Site-specific DICER and DROSHA RNA products control the DNA damage response , 2012, Nature.
[51] F. D. D. Fagagna,et al. Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation , 2012, Nature Cell Biology.
[52] Clara Correia-Melo,et al. Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence , 2012, Nature Communications.
[53] S. Jackson,et al. Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications. , 2011, Genes & development.
[54] Graziano Pesole,et al. Pscan: finding over-represented transcription factor binding site motifs in sequences from co-regulated or co-expressed genes , 2009, Nucleic Acids Res..
[55] Wilhelm Palm,et al. How shelterin protects mammalian telomeres. , 2008, Annual review of genetics.
[56] R. Korstanje,et al. The emerging role of ACE2 in physiology and disease† , 2007, The Journal of pathology.
[57] Xudong Xie,et al. Age- and gender-related difference of ACE2 expression in rat lung , 2005, Life Sciences.
[58] Xie Xudong,et al. Age- and gender-related difference of ACE2 expression in rat lung , 2005, Life Sciences.
[59] T. Lange,et al. DNA processing is not required for ATM-mediated telomere damage response after TRF2 deletion , 2005, Nature Cell Biology.
[60] John M Sedivy,et al. Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). , 2004, Molecular cell.
[61] Matthias S. Müller,et al. The Emerging Role of , 2004 .
[62] N. Carter,et al. A DNA damage checkpoint response in telomere-initiated senescence , 2003, Nature.
[63] J. Shay,et al. Telomere Shortening Is Proportional to the Size of the G-rich Telomeric 3′-Overhang* , 2000, The Journal of Biological Chemistry.
[64] Sandy Chang,et al. Longevity, Stress Response, and Cancer in Aging Telomerase-Deficient Mice , 1999, Cell.
[65] R. DePinho,et al. Essential role of mouse telomerase in highly proliferative organs , 1998, Nature.
[66] María A Blasco,et al. Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA , 1997, Cell.
[67] L. Hartwell,et al. The DNA Damage Checkpoint , 1997 .
[68] C. Harley,et al. Telomeres shorten during ageing of human fibroblasts , 1990, Nature.